2022 Behavioral Neurology & Neuropsychiatry Reading List, Learning Objectives, and CME

Reading List

Please click below to access the 2022 Behavioral Neurology & Neuropsychiatry reading list.

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty  journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

• Diagnose the varying neuropsychiatric symptoms that can occur after medical interventions and know the strategies to mitigate the effects of these symptoms
• More accurately diagnose and differentiate Alzheimer’s disease from other commonly occurring dementias, thus providing earlier and more accurate interventions and multi-disciplinary treatments
• More accurately identify causes of hallucinations in patients with neurological illnesses and provide accurate treatment interventions
• More quickly identify neuropsychiatric symptoms originating after COVID-19 survival and thus provide more timely treatments

Core Competencies

• Medical Knowledge

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within 24 hours of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1^TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry & Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved the program as a part of a comprehensive self-assessment (SA) program, which is mandates by the American Board of Medical Specialties as a necessary component of maintenance of certification. The number of ABPN SA credits granted will equal the number of CME hours claimed for the activity. 

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy. 

2022 C-cert Activity Planner Disclosures
All relevant financial relationships have been mitigated.

Behavioral Neurology & Neuropsychiatry Certification Examination Committee Contributors

Robin A. Hurley, MD, Chair, W.G. Hefner VA Medical Center
Disclosures: Nothing to disclose.

Kyle J. Steinman, MD, MAS, Vice Chair, University of Washington/Seattle Children's Hospital
Disclosures: Nothing to disclose.

James R. Bateman, III, MD, MPH, Wake Forest Baptist Medical Center
Disclosures: Nothing to disclose.

Colin J. Harrington, MD, Rhode Island Hospital and Brown University Medical School
Disclosures: Nothing to disclose.

Claudia R. Padilla, MD, Baylor Scott & White AT&T Memory Center
Disclosures: Nothing to disclose.

Jonathan H. Woodcock, MD, University of Colorado – Anschutz Medical Campus
Disclosures: Receives personal compensation for providing medical-legal/forensic services to law firms.

Michael J. Schrift, DO, MA, University of Washington
Disclosures: Nothing to disclose.

Miles G. Cunningham, MD, McLean Hospital
Disclosures: Nothing to disclose.

Mandana Modirrousta, MD, PhD, St. Boniface Hospital, Winnipeg, MB, Canada
Disclosures: Nothing to disclose.

Lindsey Gurin, MD, NYU Langone
Disclosures: Received one-time consulting fee for participation on psychiatrist advisory board regarding aducanumab.

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326